Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats-Reference-Cited by-同舟云学术

Changes in receptor activator of nuclear factor-kappaB, and its ligand, osteoprotegerin, bone-type alkaline phosphatase, and tartrate-resistant acid phosphatase in ovariectomized rats

Published:2004 Issue:3 Volume:93 Page:503-512
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J. Cell. Biochem.

Author:

Miyazaki Takashi,Matsunaga Toshiyuki,Miyazaki Shuichi,Hokari Shigeru,Komoda Tsugikazu

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference33 articles.

1. Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy x-ray absorptiometry

2. Expression and function of TNF-family proteins and receptors in human osteoblasts☆

3. Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFκB

4. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction

5. Estrogens (E2) regulate expression and response of 1,25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivation

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of Wnt Signaling Pathway by Costic Acid Derivative, An Efficient Strategy for Treatment of Glucocorticoid‐Induced Osteoporosis in Rat Model;ChemistrySelect;2023-04-03

2. Bone Remodeling in Mandible of Wistar Rats with Diabetes Mellitus and Osteoporosis;European Journal of Dentistry;2022-07-04

3. Methylbenzoxime as a therapeutic agent for glucocorticoid-induced osteoporosis in rats;Tropical Journal of Pharmaceutical Research;2021-05-13

4. The Role of Osteoporosis as a Systemic Risk Factor for Periodontal Disease;Periodontology - Fundamentals and Clinical Features [Working Title];2021-03-22

5. Novel osteoprotective nanocochleate formulation: A dual combination therapy-codelivery system against glucocorticoid induced osteoporosis;Nanomedicine: Nanotechnology, Biology and Medicine;2020-10